anonymous
Guest
anonymous
Guest
Is no one gonna bring up that bag 1 now has to “p1” bp? The aMDD market is literally 9 times the opportunity and we’re reverting back to the indication(s) that almost every AP has?! Not to mention new branded competitors with reps only talking about those patients?! I don’t understand this at all.